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Discrete populations of isotype-switched memory
B lymphocytes are maintained in murine spleen
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At present, it is not clear how memory B lymphocytes are maintained over time, and whether
only as circulating cells or also residing in particular tissues. Here we describe distinct
populations of isotype-switched memory B lymphocytes (Bsm) of murine spleen and bone
marrow, identified according to individual transcriptional signature and B cell receptor
repertoire. A population of marginal zone-like cells is located exclusively in the spleen, while a
population of quiescent Bsm is found only in the bone marrow. Three further resident
populations, present in spleen and bone marrow, represent transitional and follicular B cells
and B1 cells, respectively. A population representing 10-20% of spleen and bone marrow
memory B cells is the only one qualifying as circulating. In the bone marrow, all cells indi-
vidually dock onto VCAM1+ stromal cells and, reminiscent of resident memory T and plasma
cells, are void of activation, proliferation and mobility.
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Memory B lymphocytes, together with memory T lym-phocytes, embody one of the key features of the verte-brate immune system, the ability to memorize antigenic
challenges once encountered. A comprehensive understanding of
how memory B lymphocytes are maintained over time is key to
understand the organization of immunological memory as such.
Here we address the heterogeneity and localization of murine
memory B lymphocytes. At present, it is an open question whe-
ther, and if so which populations of memory B cells are main-
tained as circulating cells and/or as resident cells of particular
tissues, as has been described for tissue-resident memory T cells1
and resident memory plasma cells2,3.
Memory B cells expressing antibodies of switched isotype
(Bsm) have been identified in different tissues and in the blood,
and have been postulated to be part of one uniform, circulating
population4. In humans, the spleen has been identified as a major
hub for circulating Vaccinia-specific memory B cells5 and sple-
nectomy leads to gradual reduction in numbers of Bsm in the
blood to about 50%6, suggesting that tissues other than the spleen
can also serve as hubs for circulating memory B cells.
Here we dissect the heterogeneity of Bsm of spleen and bone
marrow (BM) of individual mice on the level of individual cells,
and identify one circulating and several tissue-resident popula-
tions, the latter comprising the vast majority of Bsm in those
organs. Overall, we find that most Bsm are located in the bone
marrow and spleen of inbred and feral mice. Bsm of the BM and
spleen of individual mice have significantly different repertoires,
demonstrating that they constitute separate compartments. In the
BM, Bsm rest in terms of proliferation and individually dock onto
VCAM1+/fibronectin+ stromal cells, as described for memory T
and memory plasma cells. Based on their transcriptomes, Bsm of
BM can be separated into five different clusters, four of which are
also found in the spleen. One cluster is exclusive to BM and
represents IgG1+ Bsm expressing little Cr2 and Fcer2a, encoding
CD21/35 and CD23, respectively. These Bsm are quiescent in
terms of proliferation, transcription and activation, and their B
cell receptors show an accumulation of somatic hyper-mutations.
Very few if any of these Bsm are found in the spleen. Instead, in
spleen an exclusive cluster of Bsm expressing IgG1 or IgG2, Cr2
and Fcer2a is present, with transcriptomes resembling those of
marginal zone B cells. Of the four Bsm clusters found in both
spleen and BM, two have organ-exclusive repertoires and two
have significantly overlapping repertoires. Mutational trajectories
link one of those clusters to the clusters exclusive to BM and
spleen, respectively. Thus, switched B cell memory is maintained
in shared and exclusive compartments in a secondary lymphoid
organ, i.e., the spleen, and in the BM, which harbors an exclusive
population of quiescent, affinity-matured Bsm.
Results
Bsm are abundant in spleen and bone marrow. Enumeration of
CD19+CD38+CD138−GL7− memory B cells expressing IgA,
IgG1, or IgG2b, i.e., switched memory B cells, in spleen, lymph
nodes, BM, Peyer’s patches, and blood of individual mice,
revealed that despite a large variability in total cell numbers, most
Bsm were located in spleen, BM, and lymph nodes (Table 1,
Supplementary Fig. 1a–d). In immunized C57BL/6 mice, kept
under specific pathogen-free conditions, and in mice obtained
from local pet shops, the spleen contained two to three times
more Bsm than the BM. In these immunized C57BL/6 mice and
pet shop mice, 18–41% of switched Bsm were located in the BM,
9–14% in peripheral lymph nodes and 32–60% in the spleen
(Supplementary Fig. 1c, d). Remarkably, the spleens of feral mice
(wild mice) were considerably smaller than those of C57BL/6
mice and pet shop mice (Supplementary Fig. 1e) as has been
previously reported for feral M. musculus domesticus7. These
mice had about equal numbers of Bsm in BM and spleen. While
these numbers reflect steady-state conditions in pet shop mice
and feral mice, following s.c. injection of NP-KLH with LPS as an
adjuvant, in C57BL/6 mice the vast majority of NP-specific Bsm
were located in the BM more than 420 days after immunization
(Fig. 1a), demonstrating that in this particular immune reaction,
Bsm can be preferentially maintained in the BM.
Bsm of the bone marrow are resting in G0 of cell cycle. Most
Bsm of BM and spleen are resting in terms of proliferation,
according to staining with Ki-67 (Fig. 1b). Ki-67 was expressed by
no more than 9.3% (median: 8.0%) of Bsm in spleen, and 4%
(median: 2.6%) of Bsm of BM, i.e., more than 90% of cells in the
spleen and more than 95% in the BM were in the G0 phase of cell
cycle. Accordingly, Bsm of both spleen and BM were refractory to
treatment with cyclophosphamide (Fig. 1c), a drug which elim-
inates proliferating cells. In contrast, the numbers of total CD19+
B cells of the spleen and BM were significantly reduced after one
week of cyclophospamide treatment.
Bone marrow Bsm co-localize with VCAM-1+ stromal cells. In
histological sections of the BM of Blimp1-green fluorescent pro-
tein (GFP) C57BL/6mice, we identified IgG2b+ Bsm as IgG2b+
IgD−Ki-67− nucleated cells. IgG2b+ plasma cells were excluded
from analysis according to expression of GFP under control of
the Prdm1 (Blimp1) promoter (Fig. 1d, Supplementary Fig. 1f).
IgG2b+ Bsm were dispersed as single cells throughout the BM
(Fig. 1d). In histological sections 75% of IgG2b+ Bsm were
observed in direct contact with cells expressing VCAM-1 and
fibronectin (Fig. 1e, f), and a further 15–20% of Bsm within 10 µm
vicinity of such stromal cells (Fig. 1f). 53% of the Bsm were
directly contacting laminin-expressing stromal cells, and another
26% were in the 10 µm vicinity of such cells (Fig. 1f). Contact of
IgG2b+ Bsm to VCAM-1+ stromal cells is deterministic, since it is
significantly different from random association between the two
cell types, as determined by simulation of random co-localization
(Supplementary Fig. 1g)8. The co-localization of Bsm and stromal
cells is in line with expression of VLA4 (CD49d/CD29), a receptor
for fibronectin and VCAM-1, and VLA6 (CD49f/CD29), a
receptor for laminin9, by Bsm (Fig. 1g, CD19 staining and cell size
shown in Supplementary Fig. 1h). About 10% of Bsm were in
direct contact and 26% within 10 µm vicinity of cadherin 17
(Cdh17)-expressing stromal cells (Fig. 1f).
Taken together, Bsm are abundant in BM and spleen, where
they rest in terms of proliferation. In the BM, Bsm are
individually docked onto stromal cells.
Bsm of bone marrow and spleen have distinct Ig repertoires.
Comparing the BCR repertoires of Bsm of spleen and BM of
individual mice on the level of complementarity-determining
region 3 (CDR3) of their immunoglobulin heavy chains, revealed
only marginal overlap of CDR3 repertoires between Bsm
expressing the same isotype residing in the spleen or BM of
individual mice. This is shown in Fig. 2 and Supplementary Fig. 2
for IgG1/2+ and IgA+ Bsm of three individual C57BL/6J mice,
which were immunized three times with NP-CGG. Biological and
technical replicates served to determine how representative the
samples were, and to control reproducibility (Supplementary
Fig. 2a). Cosine similarity, a measure to determine the similarity
of two groups irrespective of size, was significantly higher for
biological replicates (0.65–0.97) than between samples from
spleen and BM of each mouse (cosine similarity ~0.4) (Supple-
mentary Fig. 2b). Overall, Bsm of BM and spleen show a similar
clonal diversity and distribution of clonotype frequencies
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(Supplementary Fig. 2c, d), with the samples representing more
than 97% of the predicted entire repertoire each (Supplementary
Fig. 3 and Supplementary Table 1). To discriminate between
stochastic and directed repertoire overlap, we simulated random
overlap between two biological samples by randomly reshuffling
the sequences observed, resulting in significantly (P < 0.001)
higher overlaps (Fig. 2b, d) than those observed (Fig. 2a, c).
Remarkably, several of the most frequently expressed Ig heavy
chain V-genes were found predominantly either in the spleen or
in the BM, e.g., IGHV1-5 of mice 1 and 3 (Fig. 2e). The segre-
gation of repertoires of Bsm of spleen and BM strongly argues for
a tissue-specific compartmentalization of Bsm.
Transcriptional heterogeneity of Bsm in bone marrow and
spleen. In order to resolve the heterogeneity of Bsm within as well
as between spleen and BM, we analyzed single-cell transcriptomes
of Bsm isolated from both organs of two individual mice. Bsm
from C57BL/6J mice immunized three times with NP-CGG/
incomplete Freund’s adjuvant (IFA) i.p. 60 days prior to analysis
were enriched by MACS with CD19 microbeads (Miltenyi Bio-
tech) and isolated by FACS as IgG1+IgG2b+CD19+CD38+GL7−
CD138−IgM−IgD− cells. In total, 6047 Bsm from the spleen and
4164 from the BM were subsequently sequenced using 10×
genomics-based droplet sequencing. An average of 42,407 reads
per cell defined a median number of 1629 transcribed genes per
cell, corresponding to a sequencing saturation of approximately
70%. For 4754 Bsm from spleen and 2947 from BM, we also
determined the sequences of their antibody heavy and light chains.
In line with the isolation protocol and degree of transcriptome
saturation, most cells expressed the B cell marker genes Cd19 (86%
of all cells), Cd38 (36% of all cells), Pax5 (38% of all cells), and
Ptprc (CD45, 80% of all cells) (Supplementary Fig. 4a). Tran-
scription of Sdc1 (CD138, <0.1%, a surface protein expressed on
plasma blasts and plasma cells) and Bcl6 (2.5%, a transcription
factor characteristic for germinal center B cells) was not detectable
overall (Supplementary Fig. 4a). According to their tran-
scriptomes, Bsm robustly clustered into six different populations
(Fig. 3a). Dimensionality reduction by Uniform Manifold
Approximation and Projection (UMAP)10 was similar with regard
to cluster separation compared to t-distributed Stochastic Neigh-
bor Embedding (tSNE) plots (Supplementary Fig. 5). Bsm of
clusters I, II, III, and VI were present in both the spleen and BM of
the two mice at varying frequencies. Bsm of cluster IV were almost
exclusively located in the spleen, while Bsm of cluster V were
virtually exclusively located in the BM (Fig. 3b). While clusters III
(91% IgG1, 9% IgG2b/c) and V (94% IgG1, 6% IgG2b/c) were
predominantly cells of IgG1 isotype, cluster VI was highly enri-
ched for cells of IgG2b/2c isotype (4% IgG1, 96% IgG2b/c).
Cluster I (84% IgG1, 16% IgG2b/c), II (36% IgG1, 64% IgG2b/c),
and IV (71% IgG1, 29% IgG2b/c) consisted of cells of mixed
isotypes (Fig. 3c).
Signature genes characteristic for the different clusters are
displayed in Fig. 3d. These 45 genes represent the top predictive
genes according to sensitivity and specificity (receiver-operator
characteristics, ROC), with an area under curve (AUC) of >0.7.
Bsm of Cluster I were characterized by low levels of Cr2 (CD21)
(14% of cells in cluster 1) and intermediate levels of Fcer2a
(CD23) (52% of cluster I cells) (Fig. 3d, e). 95% expressed the
transcription factor Krueppel-like factor 2 (Klf2), 93% the
cytoskeletal protein Vimentin (Vim)11 and 62% the golgi/
endosomal-associated gene Prostate androgen-regulated mucin-
like protein 1 (Parm1)12. In summary, Bsm of cluster I resemble
transitional memory B cells13,14. 63% of Bsm of cluster II
expressed high level of Fcer2a and intermediate levels of Cr2 (24%
of cluster II Bsm). Cells of cluster II also expressed the
complement decay-accelerating factor Cd5515 in 75% of the cases
and 77% expressed the transcription factor Foxp1 (Forkhead Box
P1)16. This gene expression pattern suggests that Bsm of cluster II
are follicular memory B cells13. Bsm of cluster III resemble age-
associated memory B cells (ABC), in that they expressed low
levels of Cr2 (3%) and Fcer2a (15%). We detected high levels of
the integrin gene Itga4 (CD49d) in 91%, Itgam (CD11b) in 4%
(Supplementary Fig. 4b) and the chemokine receptor gene
CXCR3 in 47% of cluster III Bsm17. In addition, 62% of cluster
III Bsm expressed the gene encoding the calcium binding protein
S100a618. However, they lacked the expression of Itgax, the gene
encoding for CD11c (Supplementary Fig. 4b), which has been
associated with ABC (reviewed by Rubtsova et al.17). Bsm of
cluster IV, residing exclusively in the spleen, resemble marginal
zone B cells in that 53% of them expressed high levels of Cr2 and
all of them the gene Cd52, and 59% expressed intermediate levels
of Fcer2a13,19. Cluster V, found exclusively in the BM, is
comprised of Bsm expressing low levels of Cr2, and Fcer2a in 6
and 24% of Cluster V Bsm, respectively. In contrast, they
expressed relatively high levels of various genes encoding for
ribosomal proteins, such as Rps26-ps1 (76% of cluster V Bsm).
10% of cluster V Bsm also expressed the gene Cxcr4, encoding a
chemokine receptor associated with BM homing20. Bsm of cluster
VI resemble B1 cells, in that they are characterized by expression
of the scavenger receptor Cd521 in 8% (Supplementary Fig. 4b),
the Protein tyrosine phosphatase 22 gene Ptpn22 associated with
hypo-responsiveness of B cells in the context of autoimmunity22
in 56% and the gene encoding the tetraspanin Cd9 expressed on
regulatory B cells23 in 49% of the cells.
The differential expression of Cr2 (CD21/35) and Fcer2a (CD23)
by Bsm subpopulations was also evident on the protein level
Table 1 Tissue distribution of isotype-switched memory B cells.
Hygiene status Isotype Spleen Bone marrow Peripheral LN Mesenteric LN Peyer’s patches Blood
C57BL/6 SPF IgA 1976 ± 455 35,634 ± 8754 4304 ± 1398 9090 ± 3290 691 ± 560 53,033 ± 11,414
IgG1 392 ± 166 24,390 ± 9098 9995 ± 2127 10,774 ± 3760 3737 ± 1363 63,317 ± 21,266
IgG2b 2113 ± 580 106,280 ± 21,839 18,960 ± 9382 44,472 ± 9207 9287 ± 6027 283,616 ± 43,693
pet shop IgA 2130 ± 590 77,630 ± 39,883 8907 ± 1996 26,300 ± 17,838 13,013 ± 6946 61,850 ± 18,233
IgG1 2394 ± 806 148,577 ± 81,700 36,323 ± 10,256 58,646 ± 17,547 17,609 ± 6470 222,179 ± 59,635
IgG2b 9827 ± 2565 425,361 ± 223,940 147,720 ± 25,912 221,403 ± 42,907 136,631 ± 44,282 1,385,442 ± 390,533
feral IgA 2169 ± 952 12,904 ± 3853 340 ± 202 3602 ± 733 3758 ± 1624 12,873 ± 5428
IgG1 2877 ± 713 38,719 ± 12,991 797 ± 348 53,537 ± 19,914 2305 ± 784 55,717 ± 19,544
IgG2b 7373 ± 1882 73,974 ± 27,089 1321 ± 467 75,657 ± 28,597 4503 ± 1070 104,652 ± 37,075
Mean values (±SEM) of IgG1+, IgG2b+ and IgA+ CD19+CD138−CD38+CD11c−GL7−IgM−IgD− small lymphocytes; total cell numbers as calculated per organ. N= 42 (from eight experiments with five
different immunizations protocols performed in C57BL/6 mice aged 4–20 months and held under SPF conditions), 13 (feral) and 13 (pet shop).
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(Fig. 4). By flow cytometry, and using only CD21/35 and CD23 on
gated Bsm, we were able to identify populations of CD21/
35intermediate/CD23intermediate (cluster I), CD21/35intermediate
CD23high (cluster II), and CD21/35highCD23low (cluster IV) cells
in both the spleen and BM (Fig. 4a, b). Cells of clusters III, V, and
VI were among the CD21/35lowCD23low population. Within this
population, cells from cluster VI could be discriminated from
clusters III and V by their expression of CD5 (CD21/35lowCD23low/
CD5+) (Fig. 4a–c). Although cells from both clusters III and V
expressed Itga4 (CD49d), notably CD49d expression was higher in
the BM than the spleen (Fig. 1g), the presence of a population
expressing higher levels of CD49d within CD21/35lowCD23low/
CD5− cells points to an enrichment of cluster III in this population
(Fig. 4a–c). The accumulation of CXCR3 and CD11b expressing
Bsm within the CD21/35lowCD23low/CD5-/CD49dhigh cells further
supports that clusters III and V can be separated by CD49d
expression (Fig. 4a–c).
In addition to the specific gene expression signatures (Fig. 3),
Bsm of the clusters differed in the expression of gene sets
indicating physiological activitiy. Single cell gene set enrichment
analysis of expression of the Reactome24 and Gene Ontology
(GO)25–27 gene sets revealed that Bsm of both organs express
gene sets associated with oxidative phosphorylation (Reactome:
TCA/electron transport) and integrin signaling (Reactome:
integrin cell surface interactions) (Supplementary Fig. 4c), but
not gene sets associated with glycolysis or RNA polymerase II-
mediated transcription. Confirming their quiescence, Bsm of
cluster V, located exclusively in the BM, did not express gene sets
associated with BCR signaling, DNA synthesis, or regulation of
cell cycle progression. Conversely, many Bsm of cluster IV,
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located only in the spleen, expressed these gene sets. In addition,
these Bsm exclusively expressed a gene set indicating cognate
activation. Bsm of cluster III were exclusively enriched for a gene
set associated with lymphocyte migration (GO term lymphocyte
migration).
BCR repertoires and trajectories of Bsm clusters. Comparison
of the BCR repertoires (paired Ig heavy and light chain) of the
Bsm clusters I, II, and IV showed exclusive repertoires, as
determined by simulation of random distribution of BCR
sequences to the different clusters (Fig. 5a, Supplementary
Table 1), confirming the results obtained for other mice and the
bulk analysis of their Bsm of spleen and BM (Fig. 2 and Sup-
plementary Fig. 2). A significant overlap of repertoires was found
between Bsm of cluster VI from the spleen and BM. The same
was true for Bsm of clusters III and V, which showed a significant
overlap of their BCR repertoires between clusters as well as
between those of spleen and BM. Together these results imply
that those Bsm clusters were interconnected in their generation
and/or maintenance.
Bsm with a high-degree of somatic hyper-mutation (>1%
mutation in framework (FR)1-3) were more frequent in clusters I,
III, IV, and V (Fig. 5b) than in clusters II and VI. Interestingly,
the genes encoding for CD80 (Cd80) and CD273 (Pdcd1lg2),
which have been described to correlate with an increase in
somatic hypermutations28 were significantly enriched in those
clusters (Chi-squared with Yates’ correction comparing distribu-
tion of either CD80 or CD273 expressing cells in clusters I, III, IV,
and V as well as in cluster II and VI, significance level of P < 0.01).
In contrast, the number of Nt5e (CD73) expressing cells was
reduced in clusters I, III, IV, and V, as compared to random
distribution of transcription (Fig. 5b). Trajectories based on
somatic hyper-mutation of BCR heavy and light chain identified
cluster III from which clones with higher mutation counts would
have originated. A total of 187 significant clones (significantly
over-represented compared to randomization) were observed in
other clusters originating from either spleen or BM cluster III.
The frequencies of transitions, i.e., presence in more than one
cluster, are indicated in Fig. 5c, taking into account the
population size of each cluster in each organ. A trajectory was
considered significant if a P-value < 0.01 was observed (indicated
in red, Fig. 5a, c), compared to random distribution of mutated
BCR clones into different clusters. Figure 5d indicates the
direction of mutational trajectories, and the number of clones
involved. Of the 187 clones of cluster III, 55 clones were
represented with additional mutations in the very same cluster of
the other organ. Forty-five of the cluster III clones from spleen or
BM were represented with additional mutations in cluster V of
the BM, 23 clones were among the rare cells of cluster V of the
spleen. Forty clones of either spleen or BM cluster III were also
identified in cluster I of the BM, with additional mutations. There
was a significant exchange between splenic and BM cluster V (14
clones) as well as a minimal but significant exchange between the
splenic and BM cluster VI with either splenic or BM cluster II (8
clones). Additionally, we were able to detect a significant
exchange between BM cluster III and the spleen-exclusive cluster
IV (24 clones), as well as between splenic and BM cluster III and
splenic cluster V (23 clones).
In summary, mutational trajectories link cluster II to cluster VI
and cluster III to cluster V, and to lesser degree to cluster I.
Together these data suggest that Bsm of cluster III of spleen and
BM represent one interconnected compartment.
Discussion
In secondary immune responses, memory B lymphocytes provide
rapid immune protection, with antibodies of enhanced affinity
and adapted function, which is reflected by their switched isotype.
While IgM memory B cells have been shown to contribute
essentially to germinal center reactions in secondary immune
responses, Bsm have been considered to be primarily direct
precursors of plasma cells29–33. The generation of memory B
lymphocytes and their role in secondary immune responses has
been subject of intense research, but little is known about their
maintenance over time in the apparent absence of antigen. For
memory T lymphocytes, recent evidence has unveiled a highly
structured organization of their maintenance, describing popu-
lations of circulating and tissue-resident memory T cells (Trm)3.
Trm have been described for nearly all organs investigated,
including the BM8,34,35. Tissue-residency has been demonstrated
by parabiosis, solid organ transplantation, label perfusion36 but
above all, by exclusive maintenance of antigen-receptor reper-
toires in defined tissues34,37. While exclusive repertoires define
resident lymphocyte populations, besides recirculation, different
resident populations could also share repertoires, if they were
linked in generation.
Memory B lymphocytes expressing antibodies of switched
isotype can be detected in many organs, by and large with a
similar phenotype and with tetanus-specific Bsm in all organs,
Fig. 1 The bone marrow contains a major population of isotype-switched non-proliferating memory B cells. a Quantification of NP-specific IgG2a/b+
spleen, peripheral lymph nodes, blood and bone marrow (BM) memory B cells. Female C57BL/6 mice immunized with NP-KLH/LPS SC. Numbers of NP-
binding IgG2b+ cells in Spleen, BM, blood, and peripheral lymph nodes (pLN) determined by flow-cytometry on d421 or d426 post immunization; pooled
from two independent experiments. OVA ctrl: staining controls from mice immunized with the irrelevant antigen ovalbumin (OVA). Gated for IgG2b+CD19+
CD38+CD138−GL7−CD11c−IgM−IgD−PI− small lymphocytes (cf. Supplementary Fig. 5). Lines connect samples from one individual, paired one-sided t-test
for spleen and BM samples. b Flow-cytometric quantification of Ki-67 expression in IgG2b+ Bsm (IgG2b+CD19+CD38+CD138−GL7−CD11c−IgM−IgD−
PI− small lymphocytes) splenic naïve (IgM+IgD+IgG2b−CD19+CD38+CD138−GL7−CD11c− PI− small lymphocytes) and germinal center (GC) (CD19+
CD38loGL7+CD11c−PI− lymphocytes) B cells. Frequencies of Ki-67+ cells within the subset, data in right graph from two independent experiments using
pooled cells from 4 to 20 C57BL/6 mice, paired one-sided t-test. c Flow-cytometric quantification of CD19+ B cells and IgG2b+ memory B cells in female
C57BL/6J mice treated with Cyclophosphamide (CyP) or untreated controls (PBS) after immunization with 3× NP-CGG/IFA. Analysis performed after
7 days of CyP. IgG2b+ B cells quantified as IgG2b+CD19+CD38+CD138−GL7−CD11c−IgM−IgD−PI− small lymphocytes, CD19+ B cells as CD19+CD138−
PI− lymphocytes (Welch’s test, one-sided). Representative data for one of two independent experiments (n= 5 per group). Boxplot indicates median,
first and third quartiles, whiskers: 1.5 IQR. d IgG2b+ B memory cells (Ki-67− IgD− Blimp1−GFP−) are dispersed as single cells throughout the BM.
Arrows indicate IgG2b+DAPI+ cells. Scale bar: 20 µm. Micrograph representative of five slides from two female C57BL/6 mice. e Co-localization of IgG2b+
GFP−IgD−IgG2b+ cells (arrows) with mesenchymal stromal cells. Arrows indicate IgG2b+DAPI+ cells. Representative micrograph. Scale bars: 10 µm.
f Co-localization of IgG2b+ cells to mesenchymal stromal cells. Graph shows frequency of IgG2b+ cells in direct contact (black) or within 10 μm (gray) of a
cell stained for the respective molecule. g Flow cytometric quantification of surface expression of the VLA-4 and VLA-6 components CD29, CD49d, CD49f
in spleen and BM IgG2b+ Bsm. Gated for IgG2b+CD19+CD38+CD138−GL7−CD11c−IgM−IgD−PI− small lymphocytes, histogram plots representative of
three biological replicates from C57BL/6 females. Source data for Fig. 1a–c, f are provided as a Source Data file.
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arguing that Bsm form one population of interconnected
eventually circulating memory cells4. In contrast, Mamani-
Matsuda and collegues had shown that Vaccinia-specific Bsm
are mainly located in the human spleen and not in the BM, as
far as analyzed6. Recently Allie and colleagues have demon-
strated the existence of resident Bsm in murine lungs38. Here
we show that BM hosts a prominent population of memory B
lymphocytes, in particular in feral mice. This is in line with
earlier evidence, that in humans, IgM memory B cells can
migrate to the BM39. Comparison of Bsm in the spleen and BM
of individual mice, on the level of single cell transcriptomes
and antibody repertoires, demonstrates that Bsm of both
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organs comprise different compartments, and defines their
heterogeneity.
By comparing the antibody repertoires of Bsm of spleen and
BM of individual mice, we show that both organs host prominent
populations of exclusive, i.e., resident and tissue-specific, as well
as smaller populations of connected Bsm, with overlapping
repertoires. Transcriptomes of individual Bsm from murine
spleen and BM define six clusters, four of which are present in
both, spleen and BM. One is only found in spleen and another
one only in the BM.
Cluster I, a major population of Bsm in both, spleen and BM,
consists of Bsm expressing low levels of CD21 and intermediate
levels of CD23. This combination is characteristic for transitional,
immature B cells (T1/2), which are believed to represent a devel-
opmental stage of negative selection against autoreactivity in BM
(T1) and spleen (T2)13. Classical transitional B lymphocytes express
IgM and IgD, and so far40, isotype-switched transitional B cells have
not been described. However, the antigen-receptor repertoires of
Bsm of cluster I of spleen and Bm differ, as well as being distinct
from those of all other Bsm, indicating that Bsm of cluster I are
resident cells, selected in exclusive immune reactions. It should be
noted that those repertoires show a high degree of somatic hyper-
mutation, indicating an extensive selection process.
Bsm of cluster II express intermediate levels of CD21 and high
levels of CD23, a pattern reminiscent of follicular B cells, gen-
erated in germinal center reactions13. Their antigen receptor
repertoires are different between spleen and BM, and also dif-
ferent from all other Bsm. Again indicating that Bsm cluster II in
BM and spleen are resident cells, generated in different immune
reactions and most likely in germinal centers41. While their
antibodies show somatic hyper-mutation, its extent is lower than
that of most other Bsm, except those of cluster VI.
Cluster III consists of Bsm expressing low levels of CD21 and
CD23, and accumulated cells expressing CD11b and CXCR3, all
markers of “aged” memory B cells17. T-bet, another marker gene
of IgG Bsm42–45, in particular of “aged” memory B cells, was not
quantitatively detectable in the present analysis either due to the
sequencing depth or low expression of this transcription factor
per cell. “Aged” Bsm have been described to be generated in
germinal centers by combined activation of B cells through TLR
and antigen receptors42–44.
Bsm of cluster III express highly mutated antibodies, and their
repertoires overlap significantly between spleen and BM. More-
over, their repertoires also overlap with Bsm of cluster V in BM,
and the few cells of cluster V in the spleen. Interestingly, muta-
tional trajectories indicate that Bsm of cluster III are the pre-
cursors of those of cluster V. Mutational trajectories also link Bsm
of cluster III of spleen and BM, in both directions, indicating that
those clusters either would have been connected during estab-
lishment, and/or are still connected during maintenance of
memory, i.e., represent circulating Bsm. In line with this, Bsm of
cluster III are exclusively expressing a gene set associated with
lymphocyte migration.
Bsm of cluster IV are found almost exclusively in the spleen.
They express high levels of CD21 and intermediate levels of
CD23. This, together with their transcriptional signature classifies
them as marginal zone-like memory B cells13,19. Bsm of marginal
zones have been described before46. Here, we show that their
antigen receptors are highly mutated and that their repertoire is
different from the repertoire of Bsm of all other clusters, indi-
cating that they are a resident population, generated in exclusive
immune reactions.
An exclusive BM population of Bsm is seen in cluster V. Bsm
of cluster V express low levels of CD21 and CD23. They are
quiescent, as reflected by their lack of expression of gene sets
associated with BCR receptor signaling, DNA synthesis or reg-
ulation of cell cycle progression. In relation to other genes, they
express high levels of housekeeping genes encoding ribosomal
proteins47. Their antigen receptor repertoire is different from that
of Bsm of clusters I, II, IV, and VI, but shows considerable
overlap with Bsm of cluster III (see above), which according to
mutational trajectories, qualify as their precursor cells. Interest-
ingly, different from Bsm of cluster III, Bsm of cluster V, however,
do not express genes associated with migration.
Finally, Bsm of cluster VI, present in both spleen and BM, are
exclusively IgG2 expressing cells. They express CD5 and CD9,
markers of cells of the B1 lineage21. Repertoires of Bsm from
spleen and BM overlap significantly, showing that these popu-
lations have been connected in development. It should be noted,
however, that Bsm of cluster VI do not express genes associated
with lymphocyte migration in the maintenance phase of
memory.
In summary, the clustering of Bsm according to their tran-
scriptomes reveals an unforeseen heterogeneity, with populations
so far not described (clusters I, V), or poorly characterized
(cluster III, IV). The vast majority of these cells, those of clusters
I, II, IV, V, and VI are apparently permanent residents of their
tissue, since they have exclusive antigen receptor repertoires and/
or exclusive location, and they do not express genes associated
with lymphocyte migration. 10–20% of Bsm of spleen and BM,
those of cluster III, resemble “aged”memory B cells and qualify as
circulating memory B cells, with largely overlapping repertoires of
spleen and BM, and expression of genes associated with migra-
tion. Thus, as described for memory T lymphocytes3, a significant
proportion of Bsm of BM are resident. Whether they convey
preferentially long-term memory to systemic challenges, like their
T cell counterparts37, remains to be shown.
Moreover, Bsm are apparently maintained in the BM like
memory T and memory plasma cells3, where they individually
dock onto mesenchymal stromal cells, expressing VCAM1, which
provide a niche for their maintenance. We did not observe a
preferential colocalization to Cadherin-17 expressing stromal cells
Fig. 2 Spleen and bone marrow isotype-switched memory B cells are distinct in Ig heavy chain repertoire. a, c Observed overlap between the IgG1/2+ or
IgA+ heavy chain CDR3 repertoire of switched memory B cells from spleen and bone marrow (BM) or b, d random distribution (upper panels). Venn
diagrams represent clonotype presence in a given sample: numbers indicate clonotypes present in one organ exclusively or in both (overlap). Random
distributions (b, d) show median values for 1000 random distributions drawn while retaining the number of clones initially observed in the sample.
Histograms (b, d, lower panels) represent number of clonotypes in spleen and BM in 1000 randomized distributions of observed clonotypes to spleen and
BM, dashed red line indicates experimentally observed number of clonotypes present in both spleen and BM. P value of one-sided t-test for difference of
randomized overlap against observed. e VH gene recruitment to spleen and BM IgG1/2+ (upper panel) and IgA+ (lower panel) memory B cells,
represented as frequency of a particular VH gene among total CDR3s per organ. Bars show relative abundance of the ten most abundant VH genes, error
bars indicate SEM. Significance of difference in VH gene distribution to Spleen and BM assessed by MANOVA, P values corrected for multiple testing
(Benjamini-Hochberg), * indicates significant difference in means for a particular VH gene (Welch’s test, two-sided). M1–M3: replicate samples of three
female C57BL/6 mice immunized 3× NP-CGG/IFA. Only clones consistently found in technical replicates were considered. Source data for Fig. 2a–e are
provided as a Source Data file.
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of the BM, a colocalization that has been reported relevant for
Bsm of the spleen48. Instead, we observed a co-localization of
Bsm of the BM to laminin-expressing stromal cells. This is in
striking homology to IgG-secreting memory plasma cells, which
in the BM, but not in the spleen, require laminin-beta1 for their
maintenance49.
Resident Bsm of secondary lymphoid organs, e.g., the spleen,
are able to participate in secondary immune reactions, inside or
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Fig. 3 Heterogeneity of switched memory B cells is differentially represented in spleen and bone marrow. Cells for single cell sequencing were
FACSorted as IgG-expressing CD19+CD38+CD138-GL7− small lymphocytes. a Six transcriptionally defined clusters were identified by shared nearest
neighbor (SNN) modularity optimization based clustering algorithm mapped to tSNE representation of spleen and bone marrow (BM) cells. tSNE
coordinates and clustering was computed for 4754 from spleen and 2947 from BM cells, presentation is separated by organ. b Percentage of cells per
cluster in each organ by mouse. c Distribution of IgG subclass mapped on tSNE. d Signature genes for each cluster, area under curve (AUC) of receiver-
operator characteristics (ROC) of >0.7. e Distribution of transcription levels for representative genes mapped on tSNE. Cells for single cell sequencing were
FACSorted as IgG-expressing CD19+CD38+CD138−GL7− small lymphocytes from female C57BL/6 mice. Source data are provided as a Source Data file.
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outside50,51 of germinal centers. However, the raison d’être of
resident Bsm of the BM is less clear at first glance. For resident
memory T cells of the BM, we have demonstrated their effective
reactivation in the BM in immune clusters52 consisting of reac-
tivated memory T cells and antigen-presenting cells, including B
cells53. Whether or not Bsm of the BM are reactivated in a similar
way, remains to be shown. Assuming a similar reactivation, this
would be an efficient and fast way to secure rapid generation of
new (memory) plasma cells and secreted antibodies against
blood-borne antigens in situ, to provide enhanced local38 and
systemic protection. In line with this, cells of clusters I, III, IV,
and V express the highest rates of somatic hypermutation, and
they express CD80 and PD-L2 which have been associated with
high somatic hypermutation and capacity for direct
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differentiation into plasmablasts29. The contribution of BM-
resident Bsm to secondary germinal center reactions in secondary
lymphoid organs remains to be demonstrated, and it would
require their mobilization and emigration from the BM. In steady
state, only Bsm of cluster III have the transcriptional potential
to do so.
Methods
Mice. C57BL/6J/N mice were purchased from Charles River (Sulzfeld, Germany)
or Janvier Labs (Le Genest-Saint-Isle, France). Mice expressing GFP under the
control of the Prdm1 promoter (Blimp1-GFP)54 were bred at the DRFZ animal
facility. C57BL/6 and Blimp1-GFP mice were housed under specific pathogen-free
conditions. Experimental treatment and control groups were co-housed. Pet mice
were obtained as adult animals at pet shops in Berlin. Feral mice were caught as
free-living animals at non-residential farm buildings in Altlandsberg, Brandenburg,
Germany. Live traps were set up and controlled by a trained veterinarian. Mice
were anesthetized with isofluran prior to sacrifice. All animal experiments were
performed according to institutional guidelines and licensed under German animal
protection regulations by the Landesamt für Gesundheit und Soziales Berlin and
Landesamt für Arbeitsschutz, Verbraucherschutz und Gesundheit Brandenburg.
Immunizations and cyclophosphamide administration. Mice aged 8–12 weeks
were immunized s.c. with 100 μg NP-KLH 10 μg LPS (E. coli, InvivoGen). For
boost immunizations 10 μg NP-KLH without adjuvant was used. Alternatively,
mice aged 8–12 weeks were immunized three times with 100 μg NP-CGG in IFA i.
p. at 21 days interval. For further quantification of Bsm in C57BL/6 laboratory
animals, in two experiments mice were infected with 2 × 105 plaque-forming units
Armstrong strain of lymphocytic choriomeningitis virus i.p.35 or, alternatively,
infected intravenously with 106 colony-forming units of attenuated Salmonella
enterica serovar typhimurium strain SL720749.
Three times NP-CGG/ IFA-immunized (at 21 days interval) mice were i.v.
administered for one week with either Cyclophoshamide (CyP, 50 mg/kg) or PBS
starting 30 days after the last immunization. Analysis was performed on day 3 after
the last CyP injection.
Cytometry and cell sorting. In order to stain lymphocytes for multicolor flow
cytometry, cells were resuspended in PBS with 0.5% BSA and 5 µg per ml Fcγ
receptor IIB-blocking antibody (DRFZ, clone 2.4G2) or 10 µl of FcR Blocking
Reagent (Miltenyi) per 107 cells at up to 5 × 108 cells per ml. Cell separation by
FACS was done at BD FACSAria II. For cytometric analyses Canto II, Fortessa,
Symphony (BD) or MACSQuant (Miltenyi) machines were used. Data were ana-
lyzed by FlowJo (version 9, TreeStar).
Before staining, B cells were enriched by magnetic separation using anti-mouse
CD19 microbeads (Miltenyi). Antibodies against following murine antigens were
used: CD5 (53-7.3, BV786, BD OptiBuild Cat No 740842, 1:200), CD11b (M1/70,
BV650, BioLegend Cat No 101239, 1:25), CD19 (1D3, PacB DRFZ, and 1D3,
BUV395, BD Horizon Cat No 563557, 1:400), CD21/35 (76G, BUV737, BioLegend,
Cat No 62810, 1:400, and 7E9, APC-Cy7, BioLegend Cat No 123418, 1:400), CD23
(B3B4, PE-Cy7, BioLegend, Cat No 101614, 1:400), CD29 (HMß1-1, PE, Miltenyi
Cat No 130-102-602, 1:25), CD38 (90, PE-cy7, BioLegend Cat No 102718, 1:400),
CD49d (R1-2, PE, BioLegend Cat No 103608, 1:200 and REA807, VioBright515,
Miltenyi Cat No 130-111-829, 1:200), CD49f (GoH3, PE, eBioscience Cat No 12-
0495-82, 1:100), CD93 (REA298, PE, Miltenyi Cat No 130-104-157, 1:50, CD138
(281-2, PE, BD Biosciences Cat No 553714, 1:800), CXCR3 (CXCR3-173, BV605,
BioLegend Cat No 126523, 1:23), GL7 (GL7, PE, DRFZ), IgA (C10-3, FITC, BD
Biosciences Cat No 559354, 1:100), IgD (11.26c, PE, AF430, DRFZ and REA772,
PE, Miltenyi Cat No 130-111-310, 1:100), IgG1 (A85-1, FITC, BD Biosciences Cat
No 553443, 1:1000, and X-56, VioBlue, Miltenyi Cat No 130-099-089, 1:50), IgG2a/b
(R2-40, FITC 1:100, PE, 1:1000, BD Biosciences Cat No 553399 and X-57, VioBlue,
Miltenyi Cat No 130-099-083, 1:50), IgG2b (A95-1, FITC, BD Biosciences Cat No
553988, 1:800 and MRG2b-1, FITC, BioLegend Cat No 406706, 1:1000), IgM (M41,
AF405, DRFZ and REA979, PE, Miltenyi Cat No 130-116-209, 1:100) and Ki-67
(B56, PE, BD Biosciences Cat No 556027, 1:400). Dead cells were excluded using PI
staining or the Zombie Aqua Fixable Viability Kit (BioLegend). Flow cytometric
measurements and cell sorting were done according to standards defined in the
guidelines to flow cytometry and cell sorting in immunological studies55.
Single cell RNA and single cell BCR repertoire sequencings. Single-cell sus-
pensions from BM of 3× NP-CGG immunized female C57BL/6 mice were
prepared and CD19+ cells were enriched by magnetic cell sorting using anti-
CD19 microbeads (Miltenyi Biotech). Ex vivo IgG1+/IgG2b+CD19+CD38+GL7−
CD138−IgM−IgD− memory B cells were isolated by FACS (Influx cell sorter (BD
Bioscience)) and applied to the 10× Genomics platform using the Single Cell 5′
Library & Gel Bead Kit (10× Genomics) following the manufacturer’s instructions.
The amplified cDNA was used for simultaneous 5′ gene expression (GEX) and
murine BCR library preparation. BCR transcripts were amplified by Chromium
Single Cell V(D)J Enrichment Kit for murine B cells (10× Genomics). Upon
adapter ligation and index PCR, the quality of the obtained cDNA library was
assessed by Qubit quantification, Bioanalyzer fragment analysis (HS DNA Kit,
Agilent) and KAPA library quantification qPCR (Roche). The sequencing was
performed on a NextSeq500 device (Illumina) using either a High Output v2 Kit
(150 cycles) with the recommended sequencing conditions (read1: 26nt, read2:
98nt, index1: 8 nt, index2: n.a.) or a Mid Output v2 Kit (300 cycles for BCR
repertoire analysis (read1: 150 nt, read2: 150 nt, index1: 8 nt, index2: n.a., 20%
PhiX spike-in).
Single cell RNA and B cell receptor repertoire analysis. Raw sequencing data
for single cell transcriptome analysis were processed using cellranger-2.1.1. mkfastq
and count commands with default parameter settings, the genome reference:
refdata-cellranger-mm10-1.2.0 and expected-cells = 300056. Raw sequencing data
for single cell immune profiling (B cell receptor sequences (BCR) for IgG heavy and
light chain) were processed using cellranger-3.0.2. mkfastq and vdj commands with
default parameter settings and the vdj-reference: refdata-cellranger-
vdj_GRCm38_alts_ensembl-mouse-2.2.0. Only cells, which appeared in both, the
single cell transcriptome as well as immune receptor profiling were further ana-
lyzed. The high-confidence contig sequences of the isotype-switched memory B
cells were reanalyzed using HighV-QUEST at IMGT web portal for immunoglo-
bulin (IMGT) to retrieve the V-genes, J-genes, and D-genes as nucleotide and
amino acid CDR3 sequence57. IMGT-gapped-nt-sequences, V-REGION-mutation-
and-AA-change-table as well as nt-mutation-statistics were used to determine the
corresponding gapped germline FR1, CDR1, FR2, CDR2, FR3 sequences as well as
estimated mutation counts in the FR1-FR3 region. The most abundant contig for
the heavy and light BCR chain was assigned to the corresponding cell in the single
cell transcriptome analysis. Cells with incomplete heavy and light chain annotation
were removed from further analysis. In order to simulate random distribution and
determine the significance of observed BCR distribution within the transcriptomic
clusters of Bsm in the spleen and BM of the individual Bsm, their BCR were
randomly reshuffled 1000 times. For the mutation rates, the sum of the estimated
mutation counts in the light and heavy BCR chain in FR1-FR3 regions was nor-
malized by the length of the corresponding FR1-FR3 sequences. The overlap of the
BCR-repertoire was computed using the V and J-gene configuration and the
nucleotide sequence of the CDR3-Region for assessing similarity of the BCR and
the minimal fraction of common BCR in one of the compared clusters. The ana-
lysis was repeated for 1000 random annotations of the BCRs. Overlap was defined
as significantly higher or lower than expected if occurred in less than 5 or more
than 95% of randomizations. Clustering was performed using Ward2 and the
Manhattan distance. For the BCR trajectory analysis, clonal families were clustered
by the identical isotype annotation, VDJ-gene usage, gapped germline FR1-FR3
sequence and nucleotide CDR3 sequence length of the heavy and light chain. For
each clonal family a lineage tree was computed using GLaMST with concatenated
FR1-FR3 sequences of the heavy and light chain and the germline sequence as root
as input58. An accumulation of mutations was assumed between a
FR1–FR3 sequences and the first “ancestor” sequence found in the sample. For
each cluster, the proportion of ancestor sequences (member of a clonal family with
descendants with higher mutations rates) was computed. A proportion was defined
as significant if it occurred in less than 50 of 1000 randomizations (P < 0.05). For
graphical projections of trajectories, clusters were connected if a descendant-
ancestor sequence relationship was found between these clusters. Significant con-
nections between two clusters were assumed if they occured in less than 10 of the
1000 randomizations. The single cell transcriptome data was further analyzed using
Fig. 4 Surface staining of CD21/35, CD23, CD5, and CD49d resolves six distinct populations of switched memory B cells in spleen and bone marrow.
a, b Flow-cytometric identification of distinct populations among IgG+ memory B cells gated as IgG1+/IgG2b+ CD19+IgM−IgD−CD138−GL7−CD93− live
small lymphocytes (cf. Supplementary Fig. 5) in bone marrow (BM) (a) and spleen (b) of female C57BL/6 mice. CD21/35 and CD23 resolve three subsets
resembling clusters I, II, and IV as identified by transcriptional profiles. Expression of CD5 separates the CD21/35−CD23− population to a subset resembling
cluster VI while CD5− cells are divided by high and intermediate staining of CD49d into two subsets, which differ in expression of CXCR3 and CD11b and
resemble clusters III and V. Dotplots represent one of eight mice immunized 3× with NP-CGG/IFA. c Boxplots represent the frequency of subsets by
cytometry according to expression of CD21/35, CD23, CD5, and CD49d among IgG+ Bsm. A non-parametric ANOVA (Friedman test) was performed
(Two-stage linear step-up procedure of Benjamini, Krieger, and Ykutieli) P < 0.0001, followed by a one-sided paired t-test between spleen and BM cluster IV
and V, respectively, n= 8. Boxplot indicates median, first and third quartiles, whiskers: 1.5 IQR. Source data for Fig. 4c is provided as a Source Data file.
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Fig. 5 Clonal trajectories connect predominantly clusters III and V of spleen and bone marrow. a Percentage of shared clones between clusters of spleen
and bone marrow. Clones were defined according to IgG heavy and light chain genes. Clones were randomly redistributed to clusters. Overlap significantly
higher than random (P < 0.05, randomization test) indicated by red shading, white represents expected random overlap, and blue shading overlap lower
than random, i.e., exclusive repertoires. b Mutation rates (percent of nucleotide sequence; upper panel) and CD80 (Cd80), CD73 (Nt5e), and PD-Ligand 2
(Pdcd1lg2) gene expression of individual cells. Cells for single cell sequencing were isolated by FACS as IgG+CD19+CD38+CD138−GL7− small
lymphocytes. c Frequencies of Bsm clones represented with higher mutation rates in clusters listed in rows, as compared to clusters listed in columns.
Significant presence of clone members with additional mutations as compared to random distribution (P < 0.01, randomization test) is shaded in red.
d Trajectories are based on accumulation of mutations within clones. Represented are significant trajectories (P < 0.01, randomization test). Arabic
numerals indicate numbers of clones with additional mutations. Randomized redistribution of clones was performed 1000 times (a, c, d). Source data is
provided as a Source Data file.
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R 3.5.0., and Seurat R package 2.3.4. In particular, gene expression levels were
normalized and the detection of variable genes, tSNE59 as well as clustering by
shared nearest neighbor modularity optimization was performed by using 5 out of
30 principle components for tSNE and a modularity of 0.6 for clustering. In
addition, UMAP was performed in default parameter setting using 30 principle
components. The ROC for each variable gene was computed for each cluster
against the remaining cells. The ROC-values above 0.7 were clustered using Ward2
linkage, Euclidian distance. Hill numbers as well as alpha diversity measures were
computed using own scripts. For sample coverage (sample completeness, SC) the
iNEXT R package was used in default parameter settings using abundances of the
clonotypes60,61. Single cell transcriptome data as well as immune profiling data
data discussed in this publication are available at gene expression omnibus (GEO)
under accession number GSE140133.
Ig sequencing and repertoire analysis. Cells from BM (tibiae, femurae and pelvic
bones) and spleen of three times NP-CGG immunized-mice were isolated and Bsm
were magnetically enriched using the Memory B cell Isolation Kit (130-095-838
Miltenyi). Bsm were further enriched by FACSorting of CD19+CD38+CD138−
CD11c−GL7−IgM−IgD− small lymphocytes. Sorted cells of Mouse 1 and 2 were
split into two equal aliquots (samples A, B) for BM and spleen samples as cellular
(biological) replicates62. Sorted cells of Mouse 3 were split into four samples (A, B,
C, D). Biological replicates were processed independently from this point on. Cell
samples were lysed in RNA lysis buffer (R1060-1-50, Zymo Research) and stored at
−80 °C. Total RNA was extracted from samples using the ZR RNA Miniprep Kit
(Zymo Research) according to the manufacturer’s protocol (Catalog nos. R1064 &
R1065). Isolated RNA was split and library preparation was performed in technical
duplicates.
First-strand cDNA was synthesized with SMARTScribe Reverse Transcriptase
(Clontech) using total RNA, a cDNA synthesis primer mix (mIgG12ab_r1
(KKACAGTCACTGAGCTGCT), mIgG3_r (GTACAGTCACCAAGCTGCT),
mIgA_r (CCAGGTCACATTCATCGTG) by Metabion international AG) and a 5′
—template-switch adapter with unique molecular identifiers (UMI) (SmartNNNa
(AAGCAGUGGTAUCAACGCAGAGUNNNNUNNNNUNNNNUCTT(rG)4))
according to the protocol “high-quality full length immunoglobulin profiling with
unique molecular barcoding” by the Chudakov lab63. cDNA was purified with
MinElute PCR purification Kit (Qiagen) and eluted in 10 µl 70 °C nuclease-free
H2O (Qiagen).
The first PCR was performed according to the protocol of the Chudakov lab63
using a Step-out primer M1SS (AAGCAGTGGTATCAACGCA) (annealing on the
switch adapter) and a mouse IgH reverse primer mix (mIgG12_r2
(ATTGGGCAGC CCTGATTAGTGGATAGACMGATG), mIgG3_r2
(ATTGGGCAGCCCTGATTAAGGGATAGA CAGATG), mIgA_r2
(ATTGGGCAGCCCTGATTTCAGTGGGTAGATGGTG) binding to the constant
region of certain Ig heavy chains). The first PCR was performed with Q5 Hot Start
High-Fidelity DNA polymerase (NEB) in a 50 µl reaction volume using 7.5 µl of
cDNA product with following PCR parameters: 1 cycle of 95 °C for 1 min 30 s, 20
cycles of 95 °C for 10 s, 60 °C for 20 s, 72 °C for 40 s, 1 cycle of 72 °C for 4 min;
storage at 4 °C. PCR 1 products were purified with MinElute PCR purification Kit
(Qiagen) and eluted in 25 µl 70 °C nuclease-free H2O (Qiagen).
Within the second PCR amplification63 a M1S primer ((N)4–6(XXXXX)
CAGTGGTATCAACGCAGAG) (annealing on M1SS) and a step-out primer Z
((N)4-6(XXXXX)ATTGGGCAGCCCTGATT), both with sample barcodes, were
used. PCR 2 was performed with Q5 Hot Start High-Fidelity DNA polymerase
(NEB) in a 50 µl reaction volume using 2 µl of PCR 1 product with following PCR
parameters: 1 cycle of 95 °C for 1 min 30 s; 14–15 cycles of 95 °C for 10 s, 60 °C for
20 s, 72 °C for 40 s; 1 cycle of 72 °C for 4 min; storage at 4 °C. PCR 2 products were
purified with MinElute PCR purification Kit (Qiagen) and eluted in 25 µl 70 °C
nuclease-free H2O (Qiagen). The products were also gel-purified from 2% agarose
gels (extraction with MinElute gel extraction Kit (Qiagen); elution in 15 µl 70 °C
nuclease-free H2O (Qiagen).
Adapter ligation was performed using the TruSeq® DNA PCR-Free library Prep
protocol (Illumina). The products were gel-purified from 2% agarose gels instead of
bead purification as mentioned in the protocol (extraction with MinElute gel
extraction Kit (Qiagen); elution in 10 µl 70 °C nuclease-free H2O (Qiagen)).
The quality of amplified libraries was verified using an Agilent 2100 Bioanalyzer
(2100 expert High Sensitivity DNA Assay). According to the fragment size, the
libraries were quantified by qPCR using the KAPA library Quantification Kit for
Illumina platforms (KAPA Biosystems). Based on the result of the qPCR a final
library pool with a concentration of 2 pM was used for sequencing with
NextSeq500/550 (Illumina) using the NextSeq® 500/550 Mid Output Kit v2 (150
cycles) for 2 × 150 bp paired-end sequencing with 20% PhiX-library spike-in.
Ig repertoire analysis was performed using MIGEC-1.2.4a64 in default
parameter settings while adding a demultiplexing step for identification of IgG1/2,
IgG3 and IgA heavy chains. After the MIGEC pipeline’s “checkout” step isotypes
were classified according to the presence of mIgG12_r2, mIgG3_r2 and mIgA_r2
primer sequences: AGTGGATAGACMGATG, AAGGGATAGACAGATG and
TCAGTGGGTAGATGGTG, allowing for one mismatch against the primer
sequence. Data were then processed independently for each isotype. The MIGEC
segments file was adjusted to include only C57BL/6-specific V genes for mapping.
MIGEC performs a UMI-guided correction to remove PCR as well as sequencing
bias and errors. Each resulting consensus sequence was treated as one clone. Clones
with identical V and J gene compositions and CDR3 nucleotide sequences were
defined as clonotypes. Solely clonotypes consistently found in both technical
replicates of a given sample were considered in downstream analyses. Statistics on
the overlap of repertoires between different samples were performed based on the
presence of clonotypes. To assess likelihood of the observed presence of clonotypes
exclusively in one organ or an overlapping presence in both being the result of
differences in clone numbers or rare clones at purely random distribution, clones
were randomly distributed 1000 times among the samples. Random distributions of
sequences to paired samples were drawn while retaining the initial samples’
numbers of clones. Overlap statistics represent the median overlap and clonotypes
exclusive to one sample from the 1000 randomizations. The degree of similarity
between samples accounting for the abundance of clonotypes is represented by the
cosine similarity65. Hill numbers as well as alpha diversity indices were computed
using own scripts. For Sample Coverage (Sample Completeness, SC) the iNEXT R
package was used in default parameter settings using abundances of pooled
biological replicates for all colonotypes as well as colonotypes found (overlapping
clones) and not found in the different organ (unique clones)60,61. Ig repertoire data
discussed in this publication are available at GEO under accession number
GSE140133.
Statistics and data representation. Absolute numbers of mouse B cell subsets per
organ were calculated based on their frequency in a sample. For spleen, peripheral
and mesenteric lymph nodes and Peyer’s patches, total organs were prepared and
the total numbers of B cell populations calculated based on the numbers in a
defined volume determined by flow cytometry (MACSQuant, Miltenyi). BM cell
numbers were calculated analogously based on cell numbers in a single femur of a
mouse, which is estimated to harbor 6.3% of total BM leading to a conversion
factor of 7.9 from two femurs to total murine BM34.
Further analyses and statistical tests were performed within the R programming
environment66, with use of the non-base package VennDiagram67. Whiskers in
Tukey boxplots span 1.5IQR.
Preparation of histological sections and confocal microscopy. Spleens and
femoral bones were fixed in 4% Paraformaldehyde (Electron Microscopy Sciences)
for 4 h at 4 °C, equilibrated in 30% sucrose/PBS, then frozen and stored at −80 °C.
Six micrometer cryosections were stained for 1 h in 0.1% Tween-20 (Sigma-
Aldrich)/10% FCS/PBS after blocking with 10% FCS/PBS for 1 h. The following
primary and secondary reagents were used: anti-mouse IgG2b-AlexaFluor546
(RMG2b-1, BioLegend Cat No 406702, 1:100); anti-GFP-AlexaFluor488 (rabbit
polyclonal, Life Technologies Cat No A-21311, 1:100; rat monoclonal FM264G,
BioLegend Cat No 338008,1:100), anti-fibronectin (rabbit polyclonal, Sigma
Aldrich Cat No F3648,1:100), biotinylated anti-mouse Ki67 (Sol-15, eBioscience
Cat No 13-5698-82, 1:100), biotinylated anti-mouse VCAM-1 (429, eBioScience
Cat No 13-1061-82, 1:100), anti-human/mouse cadherin 17 (rabbit polyclonal,
R&D Cat No AF8524, 1:50), anti-mouse laminin (rabbit polyclonal, Sigma Aldrich
L9393, 1:100), anti-mouse IgD-AlexaFluor647 (11.26c, DRFZ), anti-mouse Thy1-
Alexa Fluor 594 (T24, DRFZ), anti-mouse B220-AlexaFluor594/647 (RA3.6B4,
DRFZ), anti-mouse CD11c-AlexaFluor647 (N418, DRFZ), donkey anti-rabbit
polyclonal IgG-AlexaFluor488/647 (Thermo Fisher Cat No A-21206,1:600), stre-
patavidin-AlexaFluor594/647 (Thermo Fisher S323561:1000). For nuclear staining,
sections were stained with 1 μg per ml DAPI in PBS. Sections were mounted in
Fluorescent Mounting Medium (DAKO). For confocal microscopy, a Zeiss
LSM710 with a 20×/0.8 numerical aperture objective lens was used. Images were
generated by tile-scans and maximum intensity projection of 3–5 Z-stacks each
with 1 μm thickness. Image acquisition was performed using Zen 2010 Version 6.0
and images were analyzed by Zen 2012 Light Edition software (Carl Zeiss
MicroImaging). Co-localization of Bsm with cells expressing other markers was
performed using sections from three biological replicates. More than 40 cells were
inspected per analysis.
Manual image analysis. Nearest neighbors of Bsm were enumerated based on
either direct cell-cell contact or a position within a 10 µm radius of cell boundaries
of Bsm using high resolution images acquired by confocal microscopy. Cells of
interest were identified by immunofluorescent staining for the marker in question.
Cells were counted as neighboring cells if pixels from both cells were in either
direct contact or within the 10 µm radius of cell boundaries.
Modeling random co-localization. To determine the probability of Bsm cells
randomly co-localizing to their observed nearest neighbors, we employed modeling
of random cell positioning, in a modification of the previously published
approach8. In brief, images of Bsm were positioned on histological images of BM at
random, repeatedly. Frequencies of co-localizing Bsm and stromal cells were then
determined and compared to the frequencies of the original histological images.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Data availability
Next Generation Sequencing data sets generated and analyzed during the current study
are available in the GEO repository under accession number GSE140133. All other data
that support the findings of this study are available on request from the corresponding
author [M.F.M.].
Received: 11 November 2019; Accepted: 3 May 2020;
References
1. Park, C. O. & Kupper, T. S. The emerging role of resident memory T cells in
protective immunity and inflammatory disease. Nat. Med. 21, 688–697 (2015).
2. Manz, R. A., Thiel, A. & Radbruch, A. Lifetime of plasma cells in the bone
marrow. Nature 388, 133–134 (1997).
3. Chang, H. D., Tokoyoda, K. & Radbruch, A. Immunological memories of the
bone marrow. Immunol. Rev. 283, 86–98 (2018).
4. Giesecke, C. et al. Tissue distribution and dependence of responsiveness of
human antigen-specific memory B cells. J. Immunol. 192, 3091–3100 (2014).
5. Mamani-Matsuda, M. et al. The human spleen is a major reservoir for long-
lived vaccinia virus-specific memory B cells. Blood 111, 4653–4659 (2008).
6. Martinez-Gamboa, L. et al. Role of the spleen in peripheral memory B-cell
homeostasis in patients with autoimmune thrombocytopenia purpura. Clin.
Immunol. 130, 199–212 (2009).
7. Abolins, S. et al. The comparative immunology of wild and laboratory mice,
Mus musculus domesticus. Nat. Commun. 8, 14811 (2017).
8. Zehentmeier, S. et al. Static and dynamic components synergize to form a
stable survival niche for bone marrow plasma cells. Eur. J. Immunol. 44,
2306–2317 (2014).
9. Lisignoli, G. et al. In vitro cultured stromal cells from human tonsils display a
distinct phenotype and induce B cell adhesion and proliferation. Eur. J.
Immunol. 26, 17–27 (1996).
10. Becht, E. et al. Dimensionality reduction for visualizing single-cell data using
UMAP. Nat. Biotechnol. 37, 38 (2018).
11. Sharma, P., Alsharif, S., Fallatah, A. & Chung, B. M. Intermediate filaments as
effectors of cancer development and metastasis: a focus on keratins, vimentin,
and nestin. Cells 8, 497 (2019).
12. Charfi, C., Levros, L. C. Jr., Edouard, E. & Rassart, E. Characterization and
identification of PARM-1 as a new potential oncogene. Mol. Cancer 12, 84
(2013).
13. Allman, D. & Pillai, S. Peripheral B cell subsets. Curr. Opin. Immunol. 20,
149–157 (2008).
14. Chung, J. B., Sater, R. A., Fields, M. L., Erikson, J. & Monroe, J. G. CD23
defines two distinct subsets of immature B cells which differ in their responses
to T cell help signals. Int. Immunol. 14, 157–166 (2002).
15. Medof, M. E. et al. Cloning and characterization of cDNAs encoding the
complete sequence of decay-accelerating factor of human complement. Proc.
Natl Acad. Sci. USA 84, 2007–2011 (1987).
16. Katoh, M. & Katoh, M. Human FOX gene family (review). Int. J. Oncol. 25,
1495–1500 (2004).
17. Rubtsova, K., Rubtsov, A. V., Cancro, M. P. & Marrack, P. Age-associated B
cells: a T-bet-dependent effector with roles in protective and pathogenic
immunity. J. Immunol. 195, 1933–1937 (2015).
18. Donato, R. et al. Functions of S100 proteins. Curr. Mol. Med. 13, 24–57
(2013).
19. Mabbott, N. A. & Gray, D. Identification of co-expressed gene signatures in
mouse B1, marginal zone and B2 B-cell populations. Immunology 141, 79–95
(2014).
20. Lim, V. Y., Zehentmeier, S., Fistonich, C. & Pereira, J. P. A chemoattractant-
guided walk through lymphopoiesis: from hematopoietic stem cells to mature
B lymphocytes. Adv. Immunol. 134, 47–88 (2017).
21. Burgueno-Bucio, E., Mier-Aguilar, C. A. & Soldevila, G. The multiple faces of
CD5. J. Leukoc. Biol. 105, 891–904 (2019).
22. Weissenberg, S. Y. et al. Identification and characterization of post-activated B
cells in systemic autoimmune diseases. Front. Immunol. 10, 2136 (2019).
23. Brosseau, C., Colas, L., Magnan, A. & Brouard, S. CD9 tetraspanin: a new
pathway for the regulation of inflammation? Front. Immunol. 9, 2316 (2018).
24. Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res.
46, D649–D655 (2018).
25. The Gene Ontology, C. The Gene Ontology Resource: 20 years and still going
strong. Nucleic Acids Res. 47, D330–D338 (2019).
26. Mi, H., Muruganujan, A., Ebert, D., Huang, X. & Thomas, P. D. PANTHER
version 14: more genomes, a new PANTHER GO-slim and improvements in
enrichment analysis tools. Nucleic Acids Res. 47, D419–D426 (2019).
27. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The
Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).
28. Tomayko, M. M., Steinel, N. C., Anderson, S. M. & Shlomchik, M. J. Cutting
edge: hierarchy of maturity of murine memory B cell subsets. J. Immunol. 185,
7146–7150 (2010).
29. Zuccarino-Catania, G. V. et al. CD80 and PD-L2 define functionally distinct
memory B cell subsets that are independent of antibody isotype. Nat.
Immunol. 15, 631–637 (2014).
30. Dogan, I. et al. Multiple layers of B cell memory with different effector
functions. Nat. Immunol. 10, 1292–1299 (2009).
31. Krishnamurty, A. T. et al. Somatically hypermutated plasmodium-specific
IgM(+) memory B cells are rapid, plastic, early responders upon malaria
rechallenge. Immunity 45, 402–414 (2016).
32. Pape, K. A., Taylor, J. J., Maul, R. W., Gearhart, P. J. & Jenkins, M. K. Different
B cell populations mediate early and late memory during an endogenous
immune response. Science 331, 1203–1207 (2011).
33. Seifert, M. et al. Functional capacities of human IgM memory B cells in early
inflammatory responses and secondary germinal center reactions. Proc. Natl
Acad. Sci. USA 112, E546–E555 (2015).
34. Tokoyoda, K. et al. Professional memory CD4+ T lymphocytes preferentially
reside and rest in the bone marrow. Immunity 30, 721–730 (2009).
35. Sercan Alp, O. et al. Memory CD8(+) T cells colocalize with IL-7(+) stromal
cells in bone marrow and rest in terms of proliferation and transcription. Eur.
J. Immunol. 45, 975–987 (2015).
36. Szabo, P. A., Miron, M. & Farber, D. L. Location, location, location: tissue
resident memory T cells in mice and humans. Sci. Immunol. 4, eaas9673
(2019).
37. Okhrimenko, A. et al. Human memory T cells from the bone marrow are
resting and maintain long-lasting systemic memory. Proc. Natl Acad. Sci. USA
111, 9229–9234 (2014).
38. Allie, S. R. et al. The establishment of resident memory B cells in the lung
requires local antigen encounter. Nat. Immunol. 20, 97–108 (2019).
39. Paramithiotis, E. & Cooper, M. D. Memory B lymphocytes migrate to bone
marrow in humans. Proc. Natl Acad. Sci. USA 94, 208–212 (1997).
40. Allman, D. et al. Resolution of three nonproliferative immature splenic B cell
subsets reveals multiple selection points during peripheral B cell maturation. J.
Immunol. 167, 6834–6840 (2001).
41. Nera, K. P., Kylaniemi, M. K. & Lassila, O. Regulation of B cell to plasma cell
transition within the follicular B cell response. Scand. J. Immunol. 82, 225–234
(2015).
42. Wang, N. S. et al. Divergent transcriptional programming of class-specific B
cell memory by T-bet and RORalpha. Nat. Immunol. 13, 604–611 (2012).
43. Knox, J. J., Myles, A. & Cancro, M. P. T-bet(+) memory B cells: generation,
function, and fate. Immunol. Rev. 288, 149–160 (2019).
44. Johnson, J. L., Scholz, J. L., Marshak-Rothstein, A. & Cancro, M. P. Molecular
pattern recognition in peripheral B cell tolerance: lessons from age-associated
B cells. Curr. Opin. Immunol. 61, 33–38 (2019).
45. Myles, A., Sanz, I. & Cancro, M. P. T-bet(+) B cells: a common denominator
in protective and autoreactive antibody responses? Curr. Opin. Immunol. 57,
40–45 (2019).
46. Hendricks, J. et al. Class-switched marginal zone B cells in spleen have
relatively low numbers of somatic mutations. Mol. Immunol. 48, 874–882
(2011).
47. Zhou, X., Liao, W. J., Liao, J. M., Liao, P. & Lu, H. Ribosomal proteins:
functions beyond the ribosome. J. Mol. Cell Biol. 7, 92–104 (2015).
48. Funakoshi, S. et al. BILL-cadherin/cadherin-17 contributes to the survival of
memory B cells. PLoS ONE 10, e0117566 (2015).
49. Manne, C. et al. Salmonella SiiE prevents an efficient humoral immune
memory by interfering with IgG(+) plasma cell persistence in the bone
marrow. Proc. Natl Acad. Sci. USA 116, 7425–7430 (2019).
50. Takemori, T., Kaji, T., Takahashi, Y., Shimoda, M. & Rajewsky, K. Generation
of memory B cells inside and outside germinal centers. Eur. J. Immunol. 44,
1258–1264 (2014).
51. Kaji, T. et al. Distinct cellular pathways select germline-encoded and
somatically mutated antibodies into immunological memory. J. Exp. Med. 209,
2079–2097 (2012).
52. Feuerer, M. et al. Bone marrow as a priming site for T-cell responses to blood-
borne antigen. Nat. Med. 9, 1151–1157 (2003).
53. Siracusa, F. et al. Nonfollicular reactivation of bone marrow resident memory
CD4 T cells in immune clusters of the bone marrow. Proc. Natl Acad. Sci. USA
115, 1334–1339 (2018).
54. Kallies, A. et al. Plasma cell ontogeny defined by quantitative changes in
blimp-1 expression. J. Exp. Med. 200, 967–977 (2004).
55. Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in
immunological studies. Eur. J. Immunol. 49, 1457–1973 (2019).
56. Addo, R. K. et al. Single-cell transcriptomes of murine bone marrow stromal
cells reveal niche-associated heterogeneity. Eur. J. Immunol. 49, 1372–1379
(2019).
57. Alamyar, E., Duroux, P., Lefranc, M. P. & Giudicelli, V. IMGT((R)) tools
for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16464-6 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:2570 | https://doi.org/10.1038/s41467-020-16464-6 | www.nature.com/naturecommunications 13
V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST
and IMGT/HighV-QUEST for NGS. Methods Mol. Biol. 882, 569–604
(2012).
58. Yang, X. et al. GLaMST: Grow Lineages along minimum spanning tree for B
cell receptor sequencing data. Preprint at https://doi.org/10.1101/465476
(2018).
59. van der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn.
Res. 9, 2579–2605 (2008).
60. Chao, A. & Jost, L. Coverage-based rarefaction and extrapolation:
standardizing samples by completeness rather than size. Ecology 93,
2533–2547 (2012).
61. Chao, A. et al. Rarefaction and extrapolation with Hill numbers: a framework
for sampling and estimation in species diversity studies. Ecol. Monogr. 84,
45–67 (2014).
62. Greiff, V. et al. Systems analysis reveals high genetic and antigen-driven
predetermination of antibody repertoires throughout B cell development. Cell
Rep. 19, 1467–1478 (2017).
63. Turchaninova, M. A. et al. High-quality full-length immunoglobulin
profiling with unique molecular barcoding. Nat. Protoc. 11, 1599–1616 (2016).
64. Shugay, M. et al. Towards error-free profiling of immune repertoires. Nat.
Methods 11, 653–655 (2014).
65. Meng, W. et al. An atlas of B-cell clonal distribution in the human body. Nat.
Biotechnol. 35, 879–884 (2017).
66. Team, R. C. R: a language and environment for statistical computing (The R
Foundation, 2018).
67. Chen, H. VennDiagram: generate high-resolution Venn and Euler plots
v1.6.19 (The R Foundation, 2018).
Acknowledgements
We thank Tuula Geske, Heidi Hecker-Kia, and Heidi Schliemann for expert technical
help, Toralf Kaiser and Jenny Kirsch for support in cell sorting, and Manuela Ohde,
Vivien Theißig and Patrick Thiemann for animal care. We thank Sven Künzel and
Christine Pfeifle, MPI for Evolutionary Biology in Plön, for providing help and
expertise on wild mice. We would like to thank Dr. Dmitriy M. Chudakov for kindly
providing the protocol for the generation of libraries for BCR receptor repertoire
sequencing. This work was supported by Deutsche Forschungsgemeinschaft through
DFG priority program 1468 IMMUNOBONE (to A.R. and H.D.C.) and the TR130 (to
A.R. and H.D.C.), and by the European Research Council through the Advanced Grant
IMMEMO (ERC-2010-AdG.20100317 Grant 268978 to A.R.). A.E.H. was funded by
the DFG (TRR130, HA5354/6-1 and HA5354/8-1). The work of R.R. and D.S. was
funded in part by the Berlin-Brandenburg School for Regenerative Therapies. R.A. was
a member of Berlin-Brandenburg School for Regenerative Therapies. J.Z. was a
member of GRK1121 (ZIBI) and M.W., K.W., and S.D. were members of International
Max Planck Research School for Infectious Diseases and Immunology Berlin (IMPRS-
IDI). M.F.M. is supported by e:Bio Innovationswettbewerb Systembiologie, a program
of the Federal Ministry of Education. Work was supported by the state of Berlin and
the “European Regional Development Fund” to G.A.H., F.H., P.M., M.M., and M.F.M.
(ERDF 2014–2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum). HDC is
funded by the Dr. Rolf M. Schwiete Foundation. The work of V.G., U.M., and S.T.R.
work was funded in part by the Swiss National Science Foundation (Project #:
31003A_143869, 31003A_170110 to STR), SystemsX.ch—AntibodyX RTD project (to
S.T.R.), Swiss Vaccine Research Institute (to S.T.R.). P.M. is supported by EUTRAIN,
a FP7 Marie Curie Initial Training Network for Early Stage Researchers funded by the
European Union. The DRFZ is a Leibniz Institute.
Author contributions
Conceptualization: R.R., M.F.M., A.R., H.D.C.; Methodology: R.R., P.D., M.F.M., A.R.;
Software: R.R., F.H., P.D.; Validation: R.R., R.A., M.F.G., D.S., C.K., R.K., J.S.; Formal
analysis: R.R., P.D., R.K., J.S., V.G., S.t.K., U.S.; Investigation: R.R., R.A., M.F.G., G.A.H.,
J.K., V.G., U.M., R.K., D.S., C.K., C.H., S.i.K., K.L., P.M., M.M.G., S.N., S.H., Ö.S.A., F.S.,
J.S., M.W., K.W., and J.Z.; Resources: V.G., R.K., Ö.S.A., R.C., A.E.H., and S.T.R.; Data
curation: R.R., F.H., P.D.; Writing—original draft: R.R., R.A., H.D.C., M.F.M., and A.R.;
Writing—Review & editing: M.F.G., V.G., A.E.H., P.D., U.M., F.S.; Visualization: R.R.,
P.D., R.A., M.F.M.; Supervision: A.R., M.F.M., H.D.C.; Project administration: M.F.M.,
A.R., H.D.C.; Funding acquisition: A.R., M.F.M.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41467-
020-16464-6.
Correspondence and requests for materials should be addressed to M.-F.M. or A.R.
Peer review information Nature Communications thanks Damien Chaussabel and the
other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer
reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2020
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16464-6
14 NATURE COMMUNICATIONS |         (2020) 11:2570 | https://doi.org/10.1038/s41467-020-16464-6 | www.nature.com/naturecommunications
